Clinical pathology

NSW spearheads key COVID-19 vaccine research

A leading group of experts in New South Wales will launch Australia’s first research to inform vaccine policy in the state and beyond. The Collaborative Research Group on Vaccines, Infections and Immunology (VIIM) will receive more than $ 4.5 million in NSW government funding over three years to study clinical …

Read More »

Seattle Cancer Care Alliance (SCCA) clinicians’ clinical oncology results to be presented at ASCO’s annual meeting in 2021

SEATTLE – (COMMERCIAL THREAD) –Seattle Cancer Care Alliance (SCCA) today announced presentations from the organization’s clinicians to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting from June 4 to 8, 2021. SCCA clinicians have contributed to studies of several types of cancer spanning the entire …

Read More »

The players in the veterinary reference laboratories market will make profitable investments during the period 2021-2026

The last Reference veterinary laboratory market The research report incorporates an easily understandable understanding of the factors that will drive and hinder the growth of the industry in the years to come. Further, it lists the different opportunities in different geographies and other submarkets followed by an in-depth look at …

Read More »

Credent’s new technological solution will be a game-changer in healthcare

During the pandemic, the diagnostics industry faced many challenges. From logistics to phlebotomists and technicians to technology, the diagnostic industry depends on different vendors to provide phlebotomists, logistics, lab technicians, technology and other services. Established in 2012 with the vision to become the leading healthcare logistics company in India, Credent …

Read More »

Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen’s LUMAKRAS ™ Inhibitor (sotorasib) KRASG12C for Use in Advanced Non-Small Cell Lung Cancer

REDWOOD CITY, Calif .– (BUSINESS WIRE) – Guardant Health, Inc. (Nasdaq: GH) announces that the United States Food and Drug Administration (FDA) has approved Guardant360® CDx assay as the first and only liquid biopsy companion diagnostic for profiling tumor mutations, or complete genomic profile, to identify patients with locally advanced …

Read More »